Skip to main content
. 2020 Oct 20;17(10):e1003374. doi: 10.1371/journal.pmed.1003374

Table 3. Associations of severe disease with listed conditions over all age groups.

Univariate Multivariable
Controls (36,948) Cases (4,272) Rate ratio (95% CI) p -Value Rate ratio (95% CI) p -Value
Care home 2,935 (8%) 1,894 (44%) 21.4 (19.1–23.9) 8 × 10−644 14.7 (13.1–16.6) 1 × 10−431
Any prescription 33,483 (91%) 4,129 (97%) 3.10 (2.59–3.71) 8 × 10−35 1.83 (1.51–2.22) 6 × 10−10
Any admission 22,538 (61%) 3,457 (81%) 2.75 (2.53–2.99) 2 × 10−124 1.56 (1.41–1.72) 1 × 10−18
Type 1 diabetes 158 (0%) 43 (1%) 2.75 (1.96–3.88) 6 × 10−9 1.56 (1.05–2.32) 0.03
Type 2 diabetes 5,542 (15%) 909 (21%) 1.60 (1.48–1.74) 8 × 10−30 1.42 (1.29–1.56) 3 × 10−13
Other/unknown type 283 (1%) 48 (1%) 1.74 (1.28–2.38) 4 × 10−4 1.58 (1.11–2.27) 0.01
Ischaemic heart disease 5,475 (15%) 906 (21%) 1.49 (1.37–1.61) 3 × 10−21 1.08 (0.98–1.20) 0.1
Other heart disease 8,610 (23%) 1,749 (41%) 2.23 (2.08–2.39) 4 × 10−109 1.33 (1.22–1.46) 2 × 10−10
Asthma or chronic airway disease 7,608 (21%) 1,434 (34%) 1.96 (1.83–2.10) 2 × 10−78 1.54 (1.42–1.68) 7 × 10−25
Chronic kidney disease or transplant recipient 202 (1%) 97 (2%) 4.06 (3.15–5.23) 3 × 10−27 2.88 (2.13–3.89) 7 × 10−12
Neurological (except epilepsy) or dementia 3,282 (9%) 1,381 (32%) 5.4 (4.9–5.8) 1 × 10−354 2.00 (1.81–2.21) 2 × 10−42
Liver disease 133 (0%) 51 (1%) 3.61 (2.60–5.00) 2 × 10−14 1.93 (1.32–2.81) 6 × 10−4
Immune deficiency or suppression 143 (0%) 40 (1%) 2.66 (1.86–3.79) 7 × 10−8 1.67 (1.10–2.52) 0.01